Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Phase I, Open-label, Multi-center Study of PIT565 in Patients with Relapsed and/or Refractory B-cell Malignancies
Study Type: Treatment
Phase: I
NCTID: NCT05397496
Principal Investigator:
Marc Hoffmann
A Phase I/II, Open Label, Single Arm, Two Part Trial to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti Tumor Activity of glofitamab in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-cell Non-Hodgkin Lymphoma
Study Type: Treatment
Phase: I/II
NCTID: NCT05533775
Principal Investigator:
Kevin Ginn
A Phase 1b/2, Open-Label, Master Protocol Study of BTK-Degrader BGB-16673 in Combination With Other Agents in Patients With Relapsed or Refractory B-Cell Malignancies
Study Type: Treatment
Phase: I/II
NCTID: NCT06634589
Principal Investigator:
Marc Hoffmann
A Randomized Phase II Trial of Consolidation Therapy Following CD19 CAR T-cell Treatment for Relapsed/Refractory Large B-cell Lymphoma or Grade IIIB Follicular Lymphoma
Study Type: Treatment
Phase: II
NCTID: NCT05633615
Principal Investigator:
Marc Hoffmann
A Phase I Study of Patient-Derived Multi-Tumor-Associated Antigen-Specific T-Cells MT-601 Administered to Patients with Relapsed or refractory Non-Hodgkin Lymphoma NHL [APOLLO]
Study Type: Treatment
Phase: I
NCTID: NCT05798897
Principal Investigator:
Haitham Abdelhakim
A Randomized Phase III Study to Evaluate Benefits of Autologous Stem Cell Transplant in Patients with Peripheral T Cell Lymphoma that Achieved a First Complete Remission CR1 Following Induction Therapy PTCL-STAT
Study Type: Treatment
Phase: III
NCTID: NCT06724237
Principal Investigator:
Marc Hoffmann
A Randomized Phase II Study of CHOEP vs CC-486- CHOEP vs duvelisib- CHOEP in previously Untreated CD30 Negative Peripheral T-cell Lymphomas
Study Type: Treatment
Phase: II
NCTID: NCT04803201
Principal Investigator:
Marc Hoffmann
Long Term Follow-Up of Patients Exposed to Lentiviral-Based CD19 directed CART Cell Therapy
Study Type: Other
Phase: N/A
NCTID: NCT02445222
Principal Investigator:
Joseph McGuirk
A Randomized Phase III Trial of Continuous Versus Intermittent Maintenance Therapy with Zanubrutinib as Upfront Treatment in Older Patients with Mantle Cell Lymphoma
Study Type: Treatment
Phase: III
NCTID: NCT05976763
Principal Investigator:
Marc Hoffmann
A Phase I Study Evaluating BAFFR-targeting CAR T cells for Patients with Relapsed or Refractory B-cell Non-Hodgkin?s Lymphoma B-NHL
Study Type: Treatment
Phase: I
NCTID: NCT05370430
Principal Investigator:
Rajat Bansal